chr16-21716941-T-C
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_144672.4(OTOA):c.1523T>C(p.Val508Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000774 in 1,614,072 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V508M) has been classified as Likely benign.
Frequency
Consequence
NM_144672.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 22Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OTOA | NM_144672.4 | c.1523T>C | p.Val508Ala | missense_variant | Exon 15 of 29 | ENST00000646100.2 | NP_653273.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| OTOA | ENST00000646100.2 | c.1523T>C | p.Val508Ala | missense_variant | Exon 15 of 29 | NM_144672.4 | ENSP00000496564.2 |
Frequencies
GnomAD3 genomes AF: 0.000973 AC: 148AN: 152102Hom.: 2 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00101 AC: 253AN: 251322 AF XY: 0.00105 show subpopulations
GnomAD4 exome AF: 0.000753 AC: 1101AN: 1461850Hom.: 1 Cov.: 32 AF XY: 0.000762 AC XY: 554AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000972 AC: 148AN: 152222Hom.: 2 Cov.: 32 AF XY: 0.00105 AC XY: 78AN XY: 74444 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 22 Uncertain:2
not provided Benign:2
not specified Benign:1
p.Val508Ala in exon 14 of OTOA: This variant is not expected to have clinical si gnificance due to a lack of conservation across species, including mammals. Of n ote 8 mammals have an alanine (Ala) at this position despite high nearby amino a cid conservation. In addition, computational analyses do not suggest a high like lihood of impact to the protein. This variant has been identified in 1% (110/101 40) of Ashkenazi Jewish chromosomes including 1 homozygote by the Genome Aggrega tion Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs138141474).
OTOA-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at